close
Breaking news

A new line of argument has already come to dominate the public sphere: it’...read more The government has gone one step further to detect community spread of the coro...read more The government has issued an order to abolish the six allowances, including the...read more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected pe...read more SEOUL| South Korea’s unemployment rate was unchanged in April as the coronavi...read more Amid the outbreak of Corona pandemic in the country, Indian government has been...read more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated ...read more Corona infection in the country is taking a macabre form. So far, more than 74 ...read more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP Chi...read more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh cror...read more

SII Granted Permission for Phase 2 and 3 of Oxford Vaccine

Russia Claims Second Corona Vaccine

A subject expert committee on Covid-19 on Friday recommended to the country’s drug regulator that the Serum Institute of India (SII) be granted the second and third stages of clinical trials on Oxford’s vaccine humans.

PTI quoted sources as saying that the recommendations of the committee, run under the Central Drugs Standard Control Organization (CDSCO), have been sent to the Drug Controller of India (DCGI) for approval.

He said SII submitted a revised proposal on Wednesday. Earlier on Tuesday, the committee of experts, after deliberating on the company’s application, asked him to change the protocol for testing and asked for some additional information from him.

An official source said, ‘The subject expert committee on Kovid-19 held an urgent meeting on Friday to consider SII’s application. After deliberation it has been recommended that the vaccine ‘Covishield’ developed by Oxford University be allowed for the second and third stages of clinical trials on humans. ‘

According to the revised proposal, the test would include 1,600 participants over the age of 18 years. These tests will be conducted at 17 selected locations including AIIMS-Delhi, BJ Medical College-Pune, RMRIMS-Patna, PGI-Chandigarh, AIIMS-Jodhpur, Nehru Hospital-Gorakhpur, Andhra Medical College-Visakhapatnam and JSS Academy of Higher Education and Research- Mysuru is included.

Story Page

Download Our Mobile App